SkyView Investment Advisors’s AbbVie ABBV Stock Holding History

SkyView Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,839	Closed	-$400K	–	241
2026 Q1	$400K	Buy	1,839 +14	+0.8%	+$3.11K	0.05%	221
2025 Q4	$417K	Sell	1,825 -470	-20%	-$107K	0.05%	230
2025 Q3	$531K	Buy	2,295 +2	+0.1%	+$407	0.07%	199
2025 Q2	$418K	Buy	2,293 +257	+13%	+$47.8K	0.06%	213
2025 Q1	$427K	Buy	+2,036	New	+$396K	0.06%	212
2023 Q4	–	Sell	-90	Closed	-$13K	–	146
2023 Q3	$13K	Sell	90 -2,137	-96%	-$314K	0.01%	343
2023 Q2	$300K	Buy	2,227 +28	+1%	+$4.11K	0.07%	316
2023 Q1	$350K	Buy	2,199 +56	+3%	+$8.56K	0.08%	278
2022 Q4	$346K	Sell	2,143 -968	-31%	-$148K	0.1%	254
2022 Q3	$418K	Buy	3,111 +280	+10%	+$40.2K	0.12%	252
2022 Q2	$434K	Buy	2,831 +728	+35%	+$111K	0.11%	255
2022 Q1	$322K	Sell	2,103 -117	-5%	-$17K	0.08%	338
2021 Q4	$300K	Buy	+2,220	New	+$262K	0.07%	334
2021 Q1	–	Sell	-2,162	Closed	-$232K	–	297
2020 Q4	$232K	Buy	+2,162	New	+$208K	0.11%	180

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SkyView Investment Advisors's ABBV Position: Q2 2026 in Review

SkyView Investment Advisors sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,839 shares — an estimated $400K sold.

SkyView Investment Advisors first reported a position in ABBV in Q4 2020 and held it in 14 quarters. The position peaked at $531K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

SkyView Investment Advisors reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
SkyView Investment Advisors sold 1,839 AbbVie shares in Q2 2026, an estimated $400K.
SkyView Investment Advisors first reported a position in AbbVie in Q4 2020 and held it in 14 quarters.
SkyView Investment Advisors's AbbVie position peaked at $531K in Q3 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.